Source: Eur Respir J 2010; 36: 503-508
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Otsuki M., Miyatake A., Fujita K., Hamasaki T., Kasayama S.. Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids. Eur Respir J 2010; 36: 503-508

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 The effect of oral steroids to changes in the carotid arteries in patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Reduction of inhaled corticosteroids in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017 Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids Source: Eur Respir J 2002; 20: Suppl. 38, 480s Year: 2002 Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001 Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Low-dose inhaled and nasal corticosteroid use and the risk of cataracts Source: Eur Respir J 2006; 27: 1168-1174 Year: 2006 Perception of the of inhaled corticosteroids role in treatment of bronchial asthma in Saudi adult patients Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004 High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004